Navigation Links
New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
Date:11/21/2008

nt in patients given sitagliptin in combination with metformin.

Dosing of JANUVIA

The recommended dose of JANUVIA is 100 mg once daily, with or without food, for all approved indications. No dosage adjustment is needed for patients with mild to moderate hepatic insufficiency or in patients with mild renal insufficiency (CrCl e 50 mL/min). To achieve plasma concentrations of JANUVIA similar to those in patients with normal renal function, lower dosages are recommended in patients with moderate and severe renal insufficiency as well as in end-stage renal disease (ESRD) patients requiring hemodialysis. For patients with moderate renal insufficiency (CrCl e 30 to < 50 mL/min), the dose of JANUVIA is 50 mg once daily. For those with severe renal insufficiency (CrCl < 30 mL/min) or with ESRD requiring dialysis, the dose of JANUVIA is 25 mg once daily. Because there is a need for dosage adjustment based upon renal function, assessment of renal function is recommended prior to initiation of JANUVIA and periodically thereafter.

Selected cautionary information for JANUVIA

Because JANUVIA is renally eliminated, and to achieve plasma concentrations of JANUVIA similar to those in patients with normal renal function, a dosage adjustment is recommended in patients with moderate renal insufficiency and in patients with severe renal insufficiency or with ESRD requiring hemodialysis or peritoneal dialysis. Safety and effectiveness of JANUVIA in pediatric patients have not been established. There are no adequate and well-controlled studies in pregnant women. JANUVIA should be used during pregnancy only if clearly needed. It is not known whether sitagliptin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when JANUVIA is administered to a nursing woman. There have been post-marketing reports of hypersensitivity reactions in patients treated with JANUVIA. These reactions include anaphy
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
2. Landmark study defines benefits of early HIV testing and treatment for infected infants
3. Study identifies causes of bone loss in breast cancer survivors
4. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
5. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
6. Rutgers researchers study cites media violence as critical risk factor for aggression
7. Brigham and Womens Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
8. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
9. New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring
10. Study investigates Gore-tex-type device to stop strokes and mini-strokes
11. The smart way to study

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 New Study Data: JANUVIA&#8482; (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 
New Study Data: JANUVIA&#8482; (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
(Date:12/2/2009)...NEAPOLIS, Dec. 3 The Am...C) has designated Hennepin Regional Poison Center ...control center - a major milestone for the center.... Regional Poison Center among 58 accredited poison...n represents a major accomplishment. It means we h...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.c...available in its catalogue: ,, Kinase Inhibit...ker.com/p0166819/Kinase-Inhibitors-Global-Markets....viding data for the years 2005 through 2008, and p...th rates (CAGRs) through 2014 ,, An overview o...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Antibiotic Resis... ,, http://www.reportlinker.com/p0166825/Antib...l-Markets.html ,, Provide an in-depth review o... antibiotics technologies ,, Offer an analysis ...
(Date:12/2/2009)... , BOSTON, Dec. 2 The Washingto...rises 8%. According to Coremetrics, a marketing o...ent on Cyber Monday compared to Cyber Monday 2008....a Sante Day Spas who reported today "Cyber Monday...t sales rose 59%" - said Tiffany Amorosino, COO of...
(Date:12/2/2009)...ng incidence of obesity could counter recent incre...(HealthDay News) -- The overall health of the U.S....es, largely because people have quit smoking in dr...oon be wiped out if the rising obesity rates among...t trends in both smoking and obesity continue unch...
Breaking Medicine News(10 mins):Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 3Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 4Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 5Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 6Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 7Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 8Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 9Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 10Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 11Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 12Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 14Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 15Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 2Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 3Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3
...Ohio New research suggests that certain small mol...make might also help doctors identify adult acute-... to therapy. , Researchers say the findings should...d the levels of molecules called microRNAs in leuk...
...onal antibody to chemo lowered toxicity, lengthene...Treatment that combines the monoclonal antibody ri...urvival in elderly patients with aggressive lympho...he February print issue of the journal. , Research...
...ions appear to be concentrating among the least ed...ns which saw higher levels of infection among the ...y in the journal AIDS. , A team led by Dr. James...ver time in sub-Saharan Africa. , HIV has spread...
...mediately Address FDA Ruling, TORONTO, Jan. 15 /P...,PreMD Inc. (TSX: PMD; Amex: PME) announced today ...t (NSE) letter from the U.S. Food and Drug,Adminis...o evaluate its options as part of the plans to add...
...R Store Gift of Mobility Answers Prayers of Disabl...d is Good!",declares Stephanie Richardson, age 56,...ties. Unable to stand or walk, and without any fam...ndependence were answered today when The SCOOTER S...
...n. 15 BeneChill, Inc., today announced it,has rec...inoChill System in,European Union member countries...-invasive, portable, and easy-to-use medical devic..." said Denise Barbut, MD, who,is founder and CEO o...
Other Medicine News:Health News:Molecules might identify high-risk acute-leukemia patients 2Health News:Combo Treatment Best for Elderly Lymphoma Patients 2Health News:HIV shifting from most to least educated in sub-Saharan Africa 2Health News:PreMD Announces FDA Decision on POC Skin Cholesterol Test 2Health News:PreMD Announces FDA Decision on POC Skin Cholesterol Test 3Health News:Philadelphia Policeman Helps Amputee Receive Power Wheelchair from The Scooter Store 2Health News:BeneChill's RhinoChill System Receives CE Marking for European Commercial Sale 2
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.c...available in its catalogue: ,, Arthroscopes - ...ker.com/p0164303/Arthroscopes---A-World-Market-Rev...e on rise, owing to their mounting scope and usage...wrists, and hips, apart from knees. The number of ...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Cardiovascular ...http://www.reportlinker.com/p0166823/Cardiovascula..., Offer a comprehensive view of the cardiovascul...vide an overview of the major types of cardiovascu...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.c...available in its catalogue: ,, Chiral Technolo... ,, http://www.reportlinker.com/p0164212/Chira...ends.html ,, The fast developing small molecu... of activity with pharmaceutical companies adding ...
Breaking Medicine Technology:Reportlinker Adds Arthroscopes - A World Market Review 2Reportlinker Adds Arthroscopes - A World Market Review 3Reportlinker Adds Arthroscopes - A World Market Review 4Reportlinker Adds Arthroscopes - A World Market Review 5Reportlinker Adds Arthroscopes - A World Market Review 6Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 2Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 3Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 4Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 5Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 6Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 7Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 8Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 9Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 10Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 11Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 12Reportlinker Adds Chiral Technology - International Technology & Market Trends 2Reportlinker Adds Chiral Technology - International Technology & Market Trends 3Reportlinker Adds Chiral Technology - International Technology & Market Trends 4Reportlinker Adds Chiral Technology - International Technology & Market Trends 5Niusule Announces Key Additions to Management Team 6243 1Niusule Announces Key Additions to Management Team 6243 2Niusule Announces Key Additions to Management Team 6243 3Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 1Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 2Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 3Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 4Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 5Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 6Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 7Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 8Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 9Tianyin Pharmaceutical co Inc Announces Record First Quarter 2010 Financial Results 6241 10Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19 6239 1Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19 6239 2
...WIRE)--May 1, 2007 - AVI BioPharma, Inc.,(Nasdaq:A...,demonstrating effectiveness of NEUGENE(R) antisen... mice. Thomas G. Voss, Ph.D.,assistant professor,... University School of Medicine, presented the data...ce on Antiviral Research on,April 30, 2007., In ex...
... /PRNewswire-FirstCall/ -- CEL-SCI,CORPORATION ann...sponse against hepatitis B antigen, and that the c...ater-in-oil adjuvant delivery,system owned by Merc... specific anti-HBV (hepatitis B virus) antibodies....rman, Senior Vice President of,Research, Cellular ...
Other Medicine Technology:AVI BioPharma Reports Positive Pre-Clinical Influenza Data 2AVI BioPharma Reports Positive Pre-Clinical Influenza Data 3CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response,Against Hepatitis B Antigen in Animals 2
Bandeau Bra
Compression Bra
...est is a clinical chemistry assay that detects Isc... cobalt binding capacity of albumin in a patient s...IMA is produced when circulating albumin comes in ...ischemia, the N-terminus of albumin is altered thr...
Osteomark NTx EIA - Serum
Medicine Products: